Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Immunology"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"610 - Medicine & health"
Showing
1
-
14
of
14
Search:
'"Immunology"'
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Seasonal influenza immunization of health care workers for the prevention of influenza in patients : a review of the clinical effectiveness
by
Seal, Kelsey
,
Spry, Carolyn
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Influenza Vaccines /
immunology
...
”
Read Now
2
Seasonal influenza immunization of health care workers for the prevention of influenza in patients : a review of the clinical effectiveness
by
Seal, Kelsey
,
Spry, Carolyn
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Influenza Vaccines /
immunology
...
”
Read Now
3
Prophylactic treatment for contacts of patients with invasive meningococcal disease on sports teams : a review of the clinical effectiveness, cost-effectiveness, and guidelines
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Meningococcal Infections /
immunology
...
”
Read Now
4
Streptococcal antigen test for pneumonia detection : a review of clinical and cost-effectiveness and guidelines
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Streptococcus pneumoniae /
immunology
...
”
Read Now
5
Clinical review report: Belimumab (Benlysta) (GlaxoSmithKline Inc.) : indication : indicated in addition to standard therapy for reducing disease activity in adult patients with ac...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Lupus Erythematosus, Systemic /
immunology
...
”
Read Now
6
Second-line therapy for patients with relapsing-remitting multiple sclerosis : a review of guidelines
by
Li, Ke Xin
,
Picheca, Lory
Published 2019
CADTH
Subjects:
“
...
Immunologic
Factors / therapeutic use...
”
Read Now
7
Recommendations for drug therapies for relapsing-emitting multiple sclerosis
Published 2013
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Immunologic
Factors / therapeutic use...
”
Read Now
8
Clinical review report: Dupilumab (Dupixent) (Sanofi genzyme, a division of Sanofi-Aventis Canada Inc.) : indication : indicated for the treatment of patients aged 12 years and old...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Immunologic
Factors / adverse effects...
”
Read Now
9
Immune checkpoint inhibitors for classical Hodgkin lymphoma in brentuximab vedotin-naïve patients : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Williams, D.
,
Gray, Casey
,
Picheca, Lory
Published 2019
CADTH
Subjects:
“
...Hodgkin Disease /
immunology
...
”
Read Now
10
Biologics versus immunomodulators or antibiotics for the management of fistulizing Crohn's disease : a review of comparative clinical effectiveness and cost-effectiveness
by
Young, Calvin
,
Campbell, Kaitryn
Published 2019
CADTH
Subjects:
“
...
Immunologic
Factors / therapeutic use...
”
Read Now
11
Biologics versus immunomodulators or antibiotics for the management of fistulizing Crohn's disease : a review of comparative clinical effectiveness and cost-effectiveness
by
Young, Calvin
,
Campbell, Kaitryn
Published 2019
CADTH
Subjects:
“
...
Immunologic
Factors / therapeutic use...
”
Read Now
12
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Immunologic
Factors / therapeutic use...
”
Read Now
13
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Immunologic
Factors / therapeutic use...
”
Read Now
14
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus-Hoffmann-La Roche Limited) : indication : management of adult patients with early primary progressive mult...
Published 2018
CADTH
Subjects:
“
...
Immunologic
Factors / economics...
”
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 610 - Medicine & health
Year of Publication
From:
To:
Classification
610 - Medicine & health
140 - Specific philosophical schools
7
330 - Economics
5
Language
English
14
Collection
National Center for Biotechnology Information
14
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
3
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
3
Campbell, Kaitryn
2
Picheca, Lory
2
Seal, Kelsey
2
more ...
Spry, Carolyn
2
Young, Calvin
2
Gray, Casey
1
Li, Ke Xin
1
Williams, D.
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22610+-+Medicine+%26+health%22&lookfor=%22Immunology%22&type=Subject
Send by Email
×
Loading...